Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Marco Dal Molin
Amanda L. Blackford
Abdulrehman Siddiqui
Aaron Brant
Christy Cho
Neda Rezaee
Jun Yu
Jin He
Matthew Weiss
Ralph H. Hruban
Christopher Wolfgang
Michael Goggins
机构：
[1] The Johns Hopkins University School of Medicine,Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center
[2] The Johns Hopkins University School of Medicine,Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center
[3] The Johns Hopkins University School of Medicine,Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center
[4] The Johns Hopkins University School of Medicine,Department of Medicine, The Sol Goldman Pancreatic Cancer Research Center
[5] Johns Hopkins Medical Institutions,Department of Pathology
来源：
Annals of Surgical Oncology | 2017年 / 24卷
关键词：
Staging System; Pancreatic Ductal Adenocarcinoma; Lymph Node Ratio; Concordance Index; Resection Margin Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2379 / 2386
页数：7
相关论文
共 50 条
  • [21] Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future
    Barhli, Aline
    Cros, Jerome
    Bartholin, Laurent
    Neuzillet, Cindy
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (10) : 979 - 990
  • [22] Outcomes and prognostic factors of resected pancreatic ductal adenocarcinoma in Saudi Arabia
    Alshammari, K.
    Samman, A.
    Alotaibi, F.
    Almugbel, F.
    Aldeheshi, A.
    AlJuhani, A.
    Al-Hajeili, M.
    Alghamdi, M.
    Alfakeeh, A.
    Alzahrani, A.
    Alghareeb, W.
    Alnekhilan, A.
    Bukhari, N.
    Qudaih, A.
    Shaheen, M.
    Shehata, H.
    Alkaiyat, M.
    Al Qahtani, J.
    Algarni, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S105 - S105
  • [23] A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
    Lingyu Zhu
    Shuo Shen
    Huan Wang
    Guoxiao Zhang
    Xiaoyi Yin
    Xiaohan Shi
    Suizhi Gao
    Jiawei Han
    Yiwei Ren
    Jian Wang
    Hui Jiang
    Shiwei Guo
    Gang Jin
    BMC Cancer, 23
  • [24] Usefulness of Inflammation-Based Prognostic Scores in Patients with Surgically Treated Pancreatic Ductal Adenocarcinoma
    Hong, Sarang
    Hwang, Dae Wook
    Lee, Jae Hoon
    Song, Ki Byung
    Lee, Woohyung
    Kwak, Bong Jun
    Park, Yejong
    Kim, Song-Cheol
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
  • [25] Prognostic Relevance of the Timing of Initiating and the Completion of Adjuvant Therapy in Patients with Resected Pancreatic Ductal Adenocarcinoma
    Woohyung Lee
    Yoo-Seok Yoon
    Ho-Seong Han
    Jin Young Jang
    Jai Young Cho
    Woohyun Jung
    Wooil Kwon
    YoungRok Choi
    Sun-Whe Kim
    World Journal of Surgery, 2017, 41 : 562 - 573
  • [26] Peripancreatic Soft Tissue Involvement: Independent Outcome Predictor in Patients With Resected Pancreatic Adenocarcinoma
    Jahromi, Alireza Hamidian
    Zibari, Gazi B.
    Jafarimehr, Elnaz
    Chu, Quyen
    Wellman, Gregory P.
    Shi, Runhua
    Johnson, Lester W.
    Shokouh-Amiri, Hosein
    INTERNATIONAL SURGERY, 2014, 99 (01) : 62 - 70
  • [27] Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma
    Ekaterina Petrova
    Verena Zielinski
    Louisa Bolm
    Cleopatra Schreiber
    Juliana Knief
    Christoph Thorns
    Peter Bronsert
    Sylvia Timme-Bronsert
    Dirk Bausch
    Sven Perner
    Tobias Keck
    Ulrich Wellner
    Virchows Archiv, 2020, 476 : 561 - 568
  • [28] Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma
    Petrova, Ekaterina
    Zielinski, Verena
    Bolm, Louisa
    Schreiber, Cleopatra
    Knief, Juliana
    Thorns, Christoph
    Bronsert, Peter
    Timme-Bronsert, Sylvia
    Bausch, Dirk
    Perner, Sven
    Keck, Tobias
    Wellner, Ulrich
    VIRCHOWS ARCHIV, 2020, 476 (04) : 561 - 568
  • [29] Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma
    Nitori, N
    Ino, Y
    Nakanishi, Y
    Yamada, T
    Honda, K
    Yanagihara, K
    Kosuge, T
    Kanai, Y
    Kitajima, M
    Hirohashi, S
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2531 - 2539
  • [30] Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma
    Michael J. Wright
    Heidi N. Overton
    Jonathan A. Teinor
    Ding Ding
    Richard A. Burkhart
    John L. Cameron
    Jin He
    Christopher L. Wolfgang
    Matthew J. Weiss
    Ammar A. Javed
    Journal of Gastrointestinal Surgery, 2020, 24 : 1590 - 1596
12345